Twelve patients (35%) were affected by diastolic dysfunction, ventricular and/or atrial dilatation, history of arrhythmia, and CHF and all were on stable ACE inhibitor or diuretic or beta-blocker treatment. The gene discussed is ACE; the disease is Arrhythmia.